Followers | 4 |
Posts | 863 |
Boards Moderated | 0 |
Alias Born | 02/10/2016 |
Wednesday, May 24, 2017 3:16:22 PM
The communications from the company during the time you are referencing time was that nothing has changed. They never actually retracted any of their older statements about their progress or about the viability of the cell. Nothing stated by the company in the meantime would cause someone who analyzed - and believed - their statements about their cell to believe it was no longer worth pursuing.
The first time the company walked back old statements was in a private conversation with an investor who shared his comments here a few weeks ago - assuming that he was accurate in relaying his account of the conversation he had with Nelson.
Details like this matter. If you took every statement the company made at it's word the timeline is more like this:
2011-2014: Cell in development, it's great, our "tests" show it is very efficient and cheap to manufacture. Could upend the entire economics of energy.
Early 2015: Major Capital Raise, which includes the cell on the prospectus.
2015-2016: We aren't focusing on developing it anymore, just need to find someone to make it. <---- This is what you are pointing out.
2017: It's dead.
At no point did they give any indication that whatever delays they had gaining a manufacturing partner had anything to do with previous reported information being untrue (especially about manufacturing costs). In fact the company touted the low manufacturing costs of the cell time and time again.
What nobody can answer is why did they not take an intermediate step and get crucial data from producing a prototype panel? Probably because they knew it was dead years ago, nothing else makes sense. If you think you have some incredible breakthrough worth billions you don't just abandon it without spending some petty cash to find out if it actually works or not.
They spent more on stock promotion than it would have cost to make a test panel, which tells you all you need to know about what this cell was ever about.
This is from an interview with Nelson from 2011:
This shows why touting low manufacturing costs was key to the investment thesis.
Of course none of this really matters since it's been a scam since the start, as the childish patent application proves.
But I guess investors should be happy they were finally told the truth AFTER losing most of their money in this. In fact since the masochistic tendencies of remaining SUNW longs seems to be off the charts... this may be true.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM